4//SEC Filing
FIVE PRIME THERAPEUTICS INC 4
Accession 0001123292-13-001404
CIK 0001175505operating
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 7:36 PM ET
Size
11.4 KB
Accession
0001123292-13-001404
Insider Transaction Report
Form 4
Douglas R Lee
Director
Transactions
- Conversion
Commom Stock
2013-09-23+4,065→ 4,065 total(indirect: By Trust) - Conversion
Commom Stock
2013-09-23+119→ 4,184 total(indirect: By Trust) - Conversion
Series A-2 Preferred Stock
2013-09-23−119→ 0 total(indirect: By Trust)→ Common Stock (119 underlying) - Conversion
Series A Preferred Stock
2013-09-23−4,065→ 0 total(indirect: By Trust)→ Common Stock (4,065 underlying)
Holdings
- 27,100
Common Stock
Footnotes (1)
- [F1]Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted into one share of common stock. The convertible preferred stock had no expiration date.
Documents
Issuer
FIVE PRIME THERAPEUTICS INC
CIK 0001175505
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175505
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 7:36 PM ET
- Size
- 11.4 KB